
INVESTOR CENTRE
Dear Investors,
Welcome to Myopharm, a clinical stage company with a strong clinical pipeline in preventing metabolic diseases. Myopharm have expert management coupled with an efficient business model and an ambitious roadmap. R&D and manufacturing, are the core of our development. Myopharm believe in long and sustainable partnerships. With the sharp rise in Prediabetes and Type 2 diabetes globally, We believe that your health cannot afford to wait.
Share Registry
Corporate Governance
Shareholder Updates
17/03/2025
Dr George Tachas and Advait Padhye joins Myopharm’s Scientific Team
06/02/2025
Myopharm strengthens clinical development team with appointment of Tamara Miller